Lactose (India) Ltd

BSE
LACTOSE •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Lactose (India) Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
259.58% Gain from 52W Low
3.6
TTM PE Ratio
Above industry Median
32
Price to Book Ratio
Below industry Median
4.6
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.1
RSI
RSI is mid-range
47.3
MFI
MFI is mid-range
34.2

Lactose (India) Ltd shareholding Pattern

Promoter
53.6%
Public
45.7%
Promoter
53.6%
Public
45.7%
Promoter
53.7%
Public
45.7%
Promoter
53.8%
Public
45.6%
Promoter
53.8%
Public
45.6%
Promoter
53.8%
Public
45.6%

Lactose (India) Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
9
5Day EMA
173.70
10Day EMA
175.40
12Day EMA
175.90
20Day EMA
176.10
26Day EMA
175.10
50Day EMA
169.00
100Day EMA
156.00
200Day EMA
133.90
5Day SMA
173.40
10Day SMA
175.30
20Day SMA
179.20
30Day SMA
180.50
50Day SMA
165.50
100Day SMA
157.40
150Day SMA
145.50
200Day SMA
127.90
Delivery & Volume
Resistance & Support
171.50
Pivot
Resistance
First Resistance
178
Second Resistance
183.40
Third Resistance
189.90
Support
First Support
166.10
Second support
159.60
Third Support
154.20
Relative Strength Index
47.27
Money Flow Index
34.18
MACD
0.77
MACD Signal
2.84
Average True Range
9.70
Average Directional Index
18.24
Rate of Change (21)
-6.12
Rate of Change (125)
14.04
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bafna Pharmaceuticals Ltd.
203.44
73.35
116.45
Lactose (India) Ltd.
-
-
-
Krebs Biochemicals & Industries Ltd.
210.19
60
121.5
Sanjivani paranteral Ltd.
-
-
-
Denis Chem Lab Ltd.
-
-
-
Vaishali Pharma Ltd.
-
-
-
Quest Laboratories Ltd.
-
-
-

Lactose (India) Ltd Company background

Founded in: 1991
Managing director: Atul Maheshwari
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad. The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose. In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.During the year 199596, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.During the year 200405, the company streamlined their pharmaceutical plant and entered into longterm contract manufacturing for one of the leading multinational company. They invested substantially in upgrading and renovating the Pharmaceutical facilities as per the requirement of the new Schedule M, as per the directives from the Food and Drug Administration. Also, they started a new equipment manufacture, assemble and export for Projects division in Kandla SEZ (Special Economic Zone).During the year 200607, the company undertook major expansion programme at their existing production site for manufacturing of value added product LACTULOSE which is a forward integration of their existing product LACTOSE.During the year 200708, the company successfully implemented the task undertaken last year and commissioned the new liquid orals division. During the year 200809, the company started manufacturing of Liquid Formulations.The Company in 2010, formed strategic alliance with Kerry Group of Ireland for contract manufacturing Of lactose 10,000 Mt / Annum.It started manufacturing for Dr Reddys for their Liquid Oral Bottles in 2015. In 2016, it started Lactulose Manufacturing API Plant. In 2022, it started own marketing sales of Lactose Monohydrate under the banner of Lactose (India) Limited.The Company in 2023, launched production of Lactulose with state of art manufacturing facility. The Plant produces Lactulose Concentrate USP Lactulose Solution USP/EP. It broadened the horizons by getting into contract manufacturing of Tablets, Liquid orals Manufacturing of Finished Formulations.
Read More

Lactose (India) Ltd FAQs

You can easily buy Lactose (India) Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -